Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RESIDENT’S CORNER
Acute bilateral ureteral obstruction secondary to guaifenesin toxicity
Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Address correspondence to Dr. Amy Krambeck, Department of Urology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905 USA
Canadian Journal of Urology 2013, 20(5), 6971-6973.
Download PDFAbstract
Several medications or their metabolites have been associated with urolithiasis, although overall they remain an infrequent cause of urolithiasis. Guaifenesin stones were originally reported as complexed with ephedrine, and subsequent reports have demonstrated pure guaifenesin stones, occurring after long term abuse. We report a case of a 23-year-old male who ingested a large, one time dose of guaifenesin, resulting in acute bilateral ureteral obstruction, which, to our knowledge, is the frst such reported case in the literature.Keywords
urolithiasis, medication, ureteral obstruction
Cite This Article
APA Style
Cockerill, P.A., Cógáin, M.R.D., Krambeck, A.E. (2013). Acute bilateral ureteral obstruction secondary to guaifenesin toxicity. Canadian Journal of Urology, 20(5), 6971–6973.
Vancouver Style
Cockerill PA, Cógáin MRD, Krambeck AE. Acute bilateral ureteral obstruction secondary to guaifenesin toxicity. Can J Urology. 2013;20(5):6971–6973.
IEEE Style
P.A. Cockerill, M.R.D. Cógáin, and A.E. Krambeck, “Acute bilateral ureteral obstruction secondary to guaifenesin toxicity,” Can. J. Urology, vol. 20, no. 5, pp. 6971–6973, 2013.
Copyright © 2013 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
